Switching Between Three Types of Mesalazine Formulation and Sulfasalazine in Patients With Active Ulcerative Colitis Who Have Already Received High-Dose Treatment With These Agents

Journal of Clinical Medicine
doi 10.3390/jcm8122109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Oral High Dose Beclomethasone Dipropionate for Treatment of Active Ulcerative Colitis

Gastroenterology Insights
HepatologyGastroenterology
2012English

Systematic Review: Safety of Mesalazine in Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Differential Expression of MUC12, MUC16, and MUC20 in Patients With Active and Remission Ulcerative Colitis

Mediators of Inflammation
ImmunologyCell Biology
2015English

IBS-like Symptoms in Patients With Ulcerative Colitis

Clinical and Experimental Gastroenterology
Gastroenterology
2015English

Correlation of Fecal Markers With Magnifying Endoscopic Stratification in Patients With Ulcerative Colitis Who Are in Clinical Remission

Digestion
Gastroenterology
2018English

Sulfasalazine Pulmonary Toxicity in Ulcerative Colitis Mimicking Clinical Features of Wegener's Granulomatosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1996English

Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Editorial: Mesalazine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy